Gates backs gene technologies in fight to end malaria

LONDON, April 18 (Reuters) – Gene-editing technologies that alter mosquitoes’ DNA could prove critical in the fight against malaria, Bill Gates said on Wednesday, and ethical concerns should not block progress in such gene-modifying research.


Source: Reuters Medical News

Abbott sticks to earlier forecasts, disappoints investors

(Reuters) – Abbott Laboratories’ just beat expectations for first quarter profits and revenue on Wednesday but stuck to a full-year profit forecast some investors had expected would be raised, sending the healthcare company’s shares lower.


Source: Reuters Medical News